Date  |
|
| Sep 8, 2020 |
9 Meters Biopharma, Inc. to Participate in September Investor Conferences |
| Aug 31, 2020 |
9 Meters Biopharma, Inc. Announces Formation of Scientific Advisory Board |
| Aug 13, 2020 |
9 Meters Biopharma, Inc. Highlighted at Upcoming Truist Securities' Catalyst Conference Call Series: "Prepping Ahead of Data" |
| Aug 12, 2020 |
9 Meters Biopharma, Inc. Provides Business Update and Announces Second Quarter 2020 Results |
| Aug 4, 2020 |
9 Meters Biopharma, Inc. to Participate in August Investor Conferences |
| Jul 28, 2020 |
9 Meters Biopharma, Inc. Announces Issuance of Patent for Use of Larazotide in Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) |
| Jul 21, 2020 |
9 Meters Biopharma, Inc. Doses the First Patients in Phase 1b/2a Clinical Trial in Short Bowel Syndrome |
| Jul 6, 2020 |
9 Meters Biopharma, Inc. Appoints Michael T. Constantino to Board of Directors |
| Jul 2, 2020 |
9 Meters Biopharma, Inc. to Participate in BMO Capital Markets' "Hidden Gems in Healthcare Conference Call Series" |
| Jun 29, 2020 |
9 Meters Biopharma, Inc. Amends Definition of Primary Endpoint for Phase 3 Trial in Celiac Disease After Consultation with FDA |